Semaglutide attenuates seizure severity and ameliorates cognitive dysfunction by blocking the NLR family pyrin domain containing 3 inflammasome in pentylenetetrazole-kindled mice.
Wang L, Ding J, Zhu C, Guo B, Yang W, He W, Li X, Wang Y, Li W, Wang F, Sun T.
Int J Mol Med. 2021 Dec;48(6):219. doi: 10.3892/ijmm.2021.5052. Epub 2021 Oct 22.
PMID:34676876
Hypoglycemic seizures and epilepsy in type I diabetes mellitus.
Falip M, Miró J, Carreño M, Jaraba S, Becerra JL, Cayuela N, Perez Maraver M, Graus F.
J Neurol Sci. 2014 Nov 15;346(1-2):307-9. doi: 10.1016/j.jns.2014.08.024. Epub 2014 Aug 27.
PMID:25183236
New insights on the potential anti-epileptic effect of metformin: Mechanistic pathway.
Alnaaim SA, Al-Kuraishy HM, Al-Gareeb AI, Ali NH, Alexiou A, Papadakis M, Saad HM, Batiha GE.
2008 Feb 8 [updated 2024 Nov 14]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
PMID:20301620
Focal Epilepsy in Individuals with Laron Syndrome.
Goldberg L, Laron Z, Kornreich L, Scheuerman O, Goldberg-Stern H, Kraus D.
Horm Res Paediatr. 2022;95(3):286-290. doi: 10.1159/000524350. Epub 2022 Mar 31.
PMID:35358968
Exploring the clinical connections between epilepsy and diabetes mellitus: Promising therapeutic strategies utilizing agmatine and metformin.
Nangia A, Saravanan JS, Hazra S, Priya V, Sudesh R, Rana SS, Ahmad F.